DrugPatentWatch Database Preview
Tafamidis meglumine - Generic Drug Details
Try a free trial
See Plans and Pricing
What are the generic drug sources for tafamidis meglumine and what is the scope of tafamidis meglumine patent protection?
Tafamidis meglumine
is the generic ingredient in one branded drug marketed by Foldrx Pharms and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Tafamidis meglumine has thirty-five patent family members in seventeen countries.
One supplier is listed for this compound.
Summary for tafamidis meglumine
| International Patents: | 35 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 6 |
| Clinical Trials: | 6 |
| Patent Applications: | 3 |
| DailyMed Link: | tafamidis meglumine at DailyMed |
Synonyms for tafamidis meglumine
| 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate |
| 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1) |
| 951395-08-7 |
| CHEBI:79345 |
| CHEMBL2105675 |
| CS-0045567 |
| D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate |
| D09674 |
| FT-0700926 |
| Fx 1006A |
| Fx-1006A |
| Fx1006A |
| HY-14852A |
| SB16821 |
| SCHEMBL14783506 |
| Tafamidis meglumine (JAN/USAN) |
| Tafamidis meglumine [USAN:INN] |
| UNII-ZU7CF08A1A |
| ZU7CF08A1A |
US Patents and Regulatory Information for tafamidis meglumine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Foldrx Pharms | VYNDAQEL | tafamidis meglumine | CAPSULE;ORAL | 211996-001 | May 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for tafamidis meglumine
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2010201263 | ➤ Sign Up |
| China | 1747965 | ➤ Sign Up |
| Japan | 4665076 | ➤ Sign Up |
| European Patent Office | 1988397 | ➤ Sign Up |
| Cyprus | 1108467 | ➤ Sign Up |
| South Africa | 200505034 | ➤ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for tafamidis meglumine
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1587821 | 1290005-6 | Sweden | ➤ Sign Up | PRODUCT NAME: TAFAMIDIS; REG. NO/DATE: EU/1/11/717/001 20111116 |
| 1587821 | 126 5003-2012 | Slovakia | ➤ Sign Up | PRODUCT NAME: TAFAMIDIS MEGLUMIN; REGISTRATION NO/DATE: EU/1/11/717/001 20111116 |
| 1587821 | CR 2012 00006 | Denmark | ➤ Sign Up | PRODUCT NAME: TAFAMIDIS (SOM MEGLUMIN); REG. NO/DATE: EU/1/11/717/001 20111116 |
| 1587821 | 2012/007 | Ireland | ➤ Sign Up | PRODUCT NAME: VYNDAQEL- TAFAMIDIS MEGLUMINE; REGISTRATION NO/DATE: EU/1/11/717/001 20111116 |
| 1587821 | 382 | Finland | ➤ Sign Up | |
| 1587821 | 6/2012 | Austria | ➤ Sign Up | PRODUCT NAME: TAFAMIDIS; REGISTRATION NO/DATE: EU/1/11/717/001 20111116 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
